Inaktiver Wert

WuXi PharmaTech (Cayman) Inc. (ADR) Aktie

Aktien

Schlusskurs Nyse Andere Börsenplätze
- ^USD	-

WuXi PharmaTech Cayman : LabNetwork Forges eCommerce Alliances with Leading Chemical Providers	27.04.16
WuXi PharmaTech Cayman : AppTec Congratulates MSD on Receiving FDA Approval of Zepatier	05.02.16
WuXi PharmaTech Cayman : AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement	12.01.16
WuXi PharmaTech Cayman : AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic	12.01.16
WuXi PharmaTech Cayman : and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China	16.12.15

Manager	Titel	Alter	Seit
Xiao Zhong Liu FOU	Founder	60	01.01.00
Zhao Hui Zhang FOU	Founder	54	01.01.00
Ge Li CEO	Chief Executive Officer	56	01.01.00

Aufsichtsräte	Titel	Alter	Seit
Ge Li CEO	Chief Executive Officer	56	01.01.00
Zhao Hui Zhang FOU	Founder	54	01.01.00
Xiao Zhong Liu FOU	Founder	60	01.01.00

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	+1,51 %	42,75 Mrd.
LONZA GROUP AG	+49,22 %	41,61 Mrd.
MODERNA, INC.	+8,57 %	41,34 Mrd.
CELLTRION, INC.	-12,36 %	26,59 Mrd.
ICON PUBLIC LIMITED COMPANY	+8,92 %	25,49 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-25,13 %	18,12 Mrd.
MEDPACE HOLDINGS, INC.	+29,17 %	12,24 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12 %	11,76 Mrd.
UNITED THERAPEUTICS CORPORATION	+6,35 %	11 Mrd.